Effects of plasmapheresis on neuromuscular transmission in myasthenia gravis
De Léan, J.
L'Union Medicale du Canada 112(1): 9-13
1983
ISSN/ISBN: 0041-6959 PMID: 6301126 Document Number: 209573
Document emailed within 1 workday
Related Documents
Hohlfeld, R. 1990: Myasthenia gravis and thymoma: paraneoplastic failure of neuromuscular transmission Laboratory Investigation; a Journal of Technical Methods and Pathology 62(3): 241-243Shibuya, N. 1978: A serum factor blocking neuromuscular transmission in myasthenia gravis: electrophysiological study with intracellular microelectrodes Rinsho Shinkeigaku 18(4): 177-184
De Crousaz, G. 1982: Indications for plasmapheresis in myasthenia gravis Therapeutische Umschau. Revue Therapeutique 39(7): 537-540
Pirskanen, R. 1979: Myasthenia gravis and other neuromuscular diseases Duodecim; Laaketieteellinen Aikakauskirja 95(21): 1401-1411
Bufler, J. 2010: Neuromuscular disease--myasthenia gravis MMW Fortschritte der Medizin 151(Suppl 4): 153-158
Pirskanen-Matell, R.; Matell, G.; Kalb, B.; Bjelak, S. 2000: Myasthenia gravis--an autoimmune neuromuscular disease Lakartidningen 97(41): 4594-4598
Tesar, V.; Jelínková, E.; Jirsa, M.; Bakosová, N.; Pit'ha, V.; Chábová, V. 1998: Soluble adhesive molecules and cytokines in patients with myasthenia gravis treated with plasmapheresis Casopis Lekaru Ceskych 137(21): 654-659
Pühringer, F.K.; Rex, C.; Renner, M.; Kazmaier, F. 2001: Undiagnosed myasthenia gravis unmasked by neuromuscular blockade British Journal of Anaesthesia 87(4): 650-651
Pittayanon, R.; Treeprasertsuk, S.; Phanthumchinda, K. 2009: Plasmapheresis or intravenous immunoglobulin for myasthenia gravis crisis in King Chulalongkorn Memorial Hospital Journal of the Medical Association of Thailand 92(4): 478-482
Nogués, M.A.; Rivero, A.; Stalberg, E. 1991: Single fiber electromyogram in myasthenia gravis and other neuromuscular diseases Medicina 51(4): 307-314
Jurenić, D.; Jusić, A. 1978: Clinical pharmacology of the neuromuscular junction in myasthenia gravis. (Preliminary communication) Neurologija 26(1-4): 37-39
Marsh, D.O. 1974: Adrenal therapy for neuromuscular disease including myasthenia gravis from 1896 New York State Journal of Medicine 74(11): 1974-1976
Monsalve Naharro, J.A.; Gerónimo Pardo, M.; Ortiz Sánchez, V.E.; Pérez Valdivieso, J.M. 2011: Sugammadex reversal of neuromuscular blockade for thymectomy in a patient with myasthenia gravis Revista Espanola de Anestesiologia y Reanimacion 58(10): 624-625
Tsujihata, M.; Hazama, R.; Ishii, N.; Ide, Y.; Takamori, M. 1979: Ultrastructural localization of the acetylcholine receptor in myasthenia gravis and in related neuromuscular diseases Rinsho Shinkeigaku 19(11): 751-759
Szobor, A. 1989: Myasthenia gravis: familial occurrence. A study of 1100 myasthenia gravis patients Acta Medica Hungarica 46(1): 13-21
Matsumoto, R.; Motomura, M.; Yoshimura, T.; Kohara, N.; Kato, T. 1999: Myasthenia gravis with electrophysiological features of Lambert-Eaton myasthenic syndrome: usefulness of serum autoantibodies assay and neuromuscular junction biopsy Rinsho Shinkeigaku 39(5): 531-537
Vincent, A.; Newsom-Davis, J. 1982: Acetylcholine receptor antibody characteristics in myasthenia gravis. II. Patients with penicillamine-induced myasthenia or idiopathic myasthenia of recent onset Clinical and Experimental Immunology 49(2): 266-272
Lechin, F.; van der Dijs, B.; Pardey-Maldonado, B.; John, E.; Jimenez, V.; Orozco, B.; Baez, S.; Lechin, M.E. 2000: Enhancement of noradrenergic neural transmission: an effective therapy of myasthenia gravis: a report on 52 consecutive patients Journal of Medicine 31(5-6): 333-361
Lohi, E.L.; Lindberg, C.; Andersen, O. 1993: Physical training effects in myasthenia gravis Archives of Physical Medicine and Rehabilitation 74(11): 1178-1180
Noguchi, S. 1976: Cell electrophoretic studies of lymphocytes. 3. Effects of administration of a massive dosage of prednisolone on lymphocyte functions in myasthenia gravis Rinsho Shinkeigaku 16(5): 373-380